Zolpidem Tartrate
Zolpidem Tartrate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Zolpidem Tartrate; Generic name: ZOLPIDEM TARTRATE; Manufacturer: Sandoz Inc.
| Brand name | Zolpidem Tartrate |
|---|---|
| Generic name | ZOLPIDEM TARTRATE |
| Manufacturer | Sandoz Inc |
| Used for | 1 INDICATIONS AND USAGE Zolpidem tartrate tablets are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate tablets have been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see Clinical Studies ( 14 )]. The clinical trials performed in support of efficacy were 4 to 5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment. Zolpidem tartrate tablets are, a gamma-aminobutyric acid (GABA) A receptor positive modulator, is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION • Use the lowest dose effective for the patient and must not exceed a total of 10 mg daily ( 2.1 ) • Treatment should be as short as possible ( 2.1 ) • Recommended initial dose is a single dose of 5 mg for women and a single dose of 5 or 10 mg for men, immediately before bedtime with at least 7 to 8 hours remaining before the planned time of awakening ( 2.1 ) • Geriatric patients and patients with mild to moderate hepatic impairment: Recommended dose is 5 mg for men a |
| Warnings | WARNING: COMPLEX SLEEP BEHAVIORS Complex sleep behaviors including sleep-walking, sleep-driving, and engaging in other activities while not fully awake may occur following use of zolpidem tartrate tablets. Some of these events may result in serious injuries, including death. Discontinue zolpidem tartrate tablets immediately if a patient experiences a complex sleep behaviors [see Contraindications ( 4 ) and Warnings and Precautions ( 5.1 )]. WARNING: COMPLEX SLEEP BEHAVIORS See full prescribing i |
| Active ingredient(s) | ZOLPIDEM TARTRATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0553e26c-f2aa-43aa-adf9-6eb951a501d3 |